Borosil Scientific Cash Flow-to-Debt Ratio
Borosil Scientific cash flow-to-debt ratio. Borosil Scientific (BOROSCI) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of Rs77.46 Million could theoretically repay 0% of its total liabilities (Rs978.97 Million) in one year. Check Borosil Scientific investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Borosil Scientific (2022–2026)
Cash flow-to-debt ratio of Borosil Scientific from 2022 to 2026. Historical debt coverage capacity for Borosil Scientific across 5 annual periods. Check Borosil Scientific cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Borosil Scientific Cash Flow-to-Debt Ratio by Year (2022–2026)
Borosil Scientific cash flow-to-debt ratio by year from 2022 to 2026. Year-by-year debt coverage analysis for Borosil Scientific. For the full cash flow conversion analysis, see Borosil Scientific (BOROSCI) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.39x | Rs424.61 Million | Rs1.08 Billion | ▼ -65.7% |
| 2025 | 1.15x | Rs1.20 Billion | Rs1.04 Billion | ▲ +348.6% |
| 2024 | 0.26x | Rs300.01 Million | Rs1.17 Billion | ▲ +1293.7% |
| 2023 | -0.02x | Rs-14.26 Million | Rs663.92 Million | ▼ -104.9% |
| 2022 | 0.44x | Rs92.19 Million | Rs208.91 Million | — |